PRMT5 and B-cell chronic lymphocytic leukemia: With this approach we could not only identify potentially deregulated genes, having an effect on the clinical prognosis of CLL, but also showed that the inhibition of one of them, PRMT5, had a growth reducing effect in CLL derived cell lines.